What is GAR Laboratories?
GAR Laboratories operates as a specialized private label manufacturer, providing comprehensive solutions for the cosmetic, hair care, and skin care industries. As an FDA-registered contract manufacturer and filler, the company distinguishes itself through a low-barrier entry model, supporting production runs starting at 5,000 units. Beyond standard manufacturing, the firm maintains a full-service R&D laboratory staffed by onsite chemists, enabling clients to transition from conceptual formulation to final retail packaging with technical precision.
The company's market position is defined by its transparency in cost-of-sales and its collaborative approach to supply chain management. By sharing component sourcing insights, GAR Laboratories effectively mitigates common pitfalls for startups, positioning itself as a strategic partner rather than a mere vendor in the health and beauty aid ecosystem.
How much funding has GAR Laboratories raised?
GAR Laboratories has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in GAR Laboratories
PPP
Public-Private Partnership
What's next for GAR Laboratories?
With this major enterprise-level funding, GAR Laboratories is well-positioned to scale its R&D infrastructure and expand its manufacturing capacity to meet rising demand for custom cosmetic formulations. The strategic allocation of this capital will likely focus on enhancing laboratory throughput and optimizing the supply chain to maintain its competitive pricing structure while scaling production volumes. As the beauty industry continues to prioritize agility and rapid time-to-market, GAR Laboratories is poised to leverage its technical expertise to capture a larger share of the contract manufacturing market, potentially diversifying its service offerings to include more complex, high-performance skincare technologies.
See full GAR Laboratories company page
